+13.1%
GSK vs HTZ
-60.6%
+73.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +9.2% | -4.1% | +4.7% |
| 7D | +4.9% | +18.9% | -14.0% | +4.3% |
| 30D | +9.9% | +26.3% | -16.4% | +8.9% |
| 3M | +0.2% | +49.7% | -49.5% | -2.0% |
| 6M | +2.3% | -61.1% | +63.4% | +6.0% |
| YTD | +7.1% | -56.0% | +63.1% | +9.9% |
| 1Y | +13.1% | -66.4% | +79.5% | +18.8% |
| All | +13.1% | -60.6% | +73.7% | +18.8% |
Cumulative growth
Daily Returns
Daily percentage return beside HTZ.
Daily Out/Under-Performance
Portfolio return minus HTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling